Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock
Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance.
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
UNCOVERED: Tandem diabetes - Caught on Camera
Unveiling 8 Analyst Insights On Tandem Diabetes Care
In the latest quarter, 8 analysts provided ratings for Tandem Diabetes Care (NASDAQ:TNDM), showcasing a mix of bullish and bearish perspectives.
Benzinga ·
Tandem Diabetes' Q1 Bottom-Line Slide Deeper Into Red Despite Sales Growth
Tandem Diabetes Care Inc (NASDAQ:TNDM) posted Q1 losses of $(0.23) deeper than $(0.08) posted a year ago and missing the consensus of $(0.07). Sales increased 25% to $175.91 million, beating the consensus of $168.43 million. Worldwide pump shipments increased 11% Y/Y to 28,095. The gross margin remained almost unchanged at 52%. The company…
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
